If you have ever wondered whether you are actually making enough progesterone, this is the kind of test that can give you a fuller answer than a single morning blood draw. β-pregnanediol is what your body excretes in urine after using progesterone, so the level reflects how much progesterone your tissues have been exposed to across hours, not just one moment.
Most women never get a real look at their progesterone activity until they are trying to conceive or struggling with cycle changes. A dried urine measurement of β-pregnanediol is one of the few practical ways to track that activity at home, on your own schedule.
Progesterone is the hormone your ovaries release in the second half of your cycle, and that the placenta produces in pregnancy. When your body finishes using it, the liver converts much of it into pregnanediol, which is then sent out through the kidneys. β-pregnanediol is the major form that ends up in urine, where it can be measured directly.
Because it is the downstream product, β-pregnanediol gives a smoothed average of progesterone activity over the collection window, rather than the sharp, minute-to-minute swings you can see in blood. That makes it useful for asking questions about overall progesterone output, not about the exact value at one timestamp.
β-pregnanediol is a research and functional-medicine marker rather than a guideline-grade clinical test. Major medical societies do not publish reference ranges or risk thresholds for it, and there is no consensus cutpoint that triggers a diagnosis. Instead, it is most often used as part of a broader urinary hormone panel to add context to clinical questions about luteal phase progesterone activity, perimenopausal hormone shifts, and how the body is processing prescribed progesterone.
Treat your result as one data point in a larger pattern. A low or high reading is a starting point for investigation, not a verdict.
There is no universally accepted reference range for β-pregnanediol in dried urine. Values depend heavily on the lab, the assay, and where you are in your cycle, so any number you get back should be compared to that lab's internal reference population and to your own prior readings rather than to a single fixed cutoff. The table below shows the general orientation labs use rather than a clinical target.
| Tier | What It Suggests |
|---|---|
| Below lab reference | Lower progesterone activity than the lab's reference population over the collection window. Common in anovulatory cycles, luteal phase issues, and postmenopause without hormone therapy. |
| Within lab reference | Progesterone activity within the typical range for the lab's reference population at your cycle stage or life stage. |
| Above lab reference | Higher progesterone activity than the lab's reference population, often reflecting current progesterone supplementation, pregnancy, or an unusually active luteal phase. |
Because cutpoints are not standardized across labs, compare your results within the same lab over time for the most meaningful trend.
A single collection can be misleading for several reasons. Hormone activity in a menstruating woman varies enormously by cycle day, with β-pregnanediol typically lowest before ovulation and rising after. Collecting at the wrong cycle phase will produce a number that looks abnormal but is actually expected for that day. Kidney function and hydration also influence how concentrated the sample is, which is why most labs report β-pregnanediol normalized to creatinine.
One reading of β-pregnanediol tells you less than two or three readings taken at the same phase of your cycle across consecutive months. Progesterone output naturally varies cycle to cycle, especially in your late 30s and 40s, so a single low value should not be treated as a diagnosis. If you are trying to conceive, repeating the test in the mid-luteal phase across two or three cycles gives you a much clearer picture than any one measurement.
A reasonable cadence is a baseline collection at a defined cycle phase (typically days 19 to 22 in a 28-day cycle), a follow-up in the next one or two cycles if you are making changes or starting therapy, and then at least annually if you are tracking long-term reproductive or perimenopausal patterns.
If your β-pregnanediol comes back unexpectedly low for the cycle phase you collected in, the next step is not to start progesterone on your own. It is to confirm with a mid-luteal serum progesterone draw and to look at the rest of the urinary hormone panel, especially estradiol metabolites and the cortisol pattern, to see whether the picture suggests an anovulatory cycle, a short luteal phase, or a broader hormonal pattern. Persistent low values across cycles in someone with cycle irregularity, infertility, or recurrent miscarriage are worth discussing with a reproductive endocrinologist or a gynecologist familiar with functional hormone testing.
A high value almost always traces back to either exogenous progesterone exposure, pregnancy, or a healthy luteal phase. If none of those apply, retesting and a broader workup are reasonable.
b-Pregnanediol is best interpreted alongside these tests.